论文部分内容阅读
目的:评价疏血通治疗急性脑梗死(ACI)的临床疗效。方法:118例急性脑梗死患者随机分成治疗组和对照组。治疗组用疏血通注射液6 mL每日1次静脉滴注,15 d为1个疗程;采用通常的治疗方案,给予低分子右旋糖酐静滴,口服肠溶阿司匹林100 mg·d-1,有脑水肿给予20%甘露醇脱水等常规治疗。评价治疗前和治疗后的神经功能缺损评分。结果:治疗组与对照组比较,神经功能缺损评分改善显著(P<0.01),治疗组显效率高于对照组(P<0.01)。结论:疏血通注射液治疗急性脑梗死比常规治疗效果好,并且安全、简便和可靠。
Objective: To evaluate the clinical efficacy of Shuxuetong in the treatment of acute cerebral infarction (ACI). Methods: 118 patients with acute cerebral infarction were randomly divided into treatment group and control group. The treatment group with Shuxuetong injection 6 mL once daily intravenous infusion, 15 d for a course of treatment; the usual treatment options, given low molecular weight dextran intravenous, oral enteric-coated aspirin 100 mg · d-1, there Brain edema given 20% mannitol and other conventional treatment of dehydration. Neurological deficit scores were evaluated before and after treatment. Results: Compared with the control group, the neurological deficit score improved significantly (P <0.01), and the effective rate of the treatment group was significantly higher than that of the control group (P <0.01). Conclusion: Shuxuetong injection in treating acute cerebral infarction is more effective than conventional treatment and safe, simple and reliable.